Blackstone Inc
VYGR icon

Blackstone Inc’s Voyager Therapeutics VYGR Stock Holding History

Blackstone Inc’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50,848
Closed -$473K – 196
2024
Q1 		$473K Hold
50,848
– – ﹤0.01% 152
2023
Q4 		$429K Hold
50,848
– – ﹤0.01% 141
2023
Q3 		$394K Hold
50,848
– – ﹤0.01% 139
2023
Q2 		$582K Buy
50,848
+16,129
+46% +$167K ﹤0.01% 135
2023
Q1 		$268K Buy
34,719
+7,548
+28% +$60K ﹤0.01% 147
2022
Q4 		$166K Hold
27,171
– – ﹤0.01% 157
2022
Q3 		$161K Hold
27,171
– – ﹤0.01% 197
2022
Q2 		$161K Hold
27,171
– – ﹤0.01% 223
2022
Q1 		$207K Hold
27,171
– – ﹤0.01% 218
2021
Q4 		$74K Hold
27,171
– – ﹤0.01% 474
2021
Q3 		$71K Buy
+27,171
New +$88.3K ﹤0.01% 568

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Blackstone Inc's VYGR Position: Q2 2024 in Review

Blackstone Inc sold out of Voyager Therapeutics (VYGR) in Q2 2024, closing a stake of 50,848 shares — an estimated $473K sold.

Blackstone Inc first reported a position in VYGR in Q3 2021 and held it in 11 quarters. The position peaked at $582K in Q2 2023. 127 funds tracked by Wall St. Rank hold VYGR as of Q2 2024.

  • Blackstone Inc reported no remaining Voyager Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Blackstone Inc sold 50,848 Voyager Therapeutics shares in Q2 2024, an estimated $473K.
  • Blackstone Inc first reported a position in Voyager Therapeutics in Q3 2021 and held it in 11 quarters.
  • Blackstone Inc's Voyager Therapeutics position peaked at $582K in Q2 2023.
  • 127 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2024.

Based on Blackstone Inc's 13F filing for Q2 2024, filed 14 Aug 2024.